SFN increased RUNX2 transcriptional activation, AURKA stimulation through TPX2, and IL-10 signaling, while inhibiting the process of white and brown adipocyte differentiation, an underlying mechanism whose inactivation might result in obesity, according to our pathway enrichment study. The gene discussed is SFN; the disease is obesity due to melanocortin 4 receptor deficiency.